THE SWISS HELVETIA FUND, INC.
|
|
Schedule of Investments by Industry (Unaudited)
|
|
September 30, 2024
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Percent
|
|
No. of
|
|
|
|
|
|
|
of Net
|
|
Shares
|
|
Security
|
|
Value
|
|
|
Assets
|
|
Common Stock — 93.38%
|
|
|
|
|
|
|
Advertising — 0.48%
|
|
|
|
|
|
|
|
8,000
|
|
DKSH Holding AG
|
|
|
637,307
|
|
|
|
0.48
|
%
|
|
|
|
An international marketing and services group. The company offers a comprehensive package of services that includes organizing and
running the entire value chain for any product.
|
|
|
|
|
|
|
|
|
|
|
|
(Cost $515,995)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
637,307
|
|
|
|
0.48
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
Banks — 3.22%
|
|
|
|
|
|
|
|
|
|
1,500
|
|
St Galler Kantonalbank AG
|
|
|
737,064
|
|
|
|
0.55
|
%
|
|
|
|
St. Galler Kantonalbank AG is a Swiss Regional bank. The Bank offers retail and commercial banking as well as private and
institutional banking. SGKB also provides asset management and financial planing services. The Bank offers its services in the Canton of St. Gall through a network of branches.
|
|
|
|
|
|
|
|
|
|
|
|
(Cost $753,505)
|
|
|
|
|
|
|
|
|
|
116,000
|
|
UBS Group AG
|
|
|
3,583,617
|
|
|
|
2.67
|
%
|
|
|
|
Provides retail banking, corporate and institutional banking, wealth management, asset management and investment banking.
|
|
|
|
|
|
|
|
|
|
|
|
(Cost $1,582,000)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4,320,681
|
|
|
|
3.22
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
Biotechnology — 2.33%
|
|
|
|
|
|
|
|
|
|
10,801
|
|
Bachem Holding AG
|
|
|
911,660
|
|
|
|
0.68
|
%
|
|
|
|
Specializes in the development and manufacture of peptides and oligonucleotides. The company provides products for research, clinical
development and commercial application to pharamceutical and biotechnology companies.
|
|
|
|
|
|
|
|
|
|
|
|
(Cost $827,767)
|
|
|
|
|
|
|
|
|
|
3,500
|
|
Lonza Group AG
|
|
|
2,218,126
|
|
|
|
1.65
|
%
|
|
|
|
Produces organic fine chemicals, biocides, active ingredients, and biotechnology products.
|
|
|
|
|
|
|
|
|
|
|
|
(Cost $1,871,039)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3,129,786
|
|
|
|
2.33
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
Building Materials — 2.01%
|
|
|
|
|
|
|
|
|
|
8,100
|
|
Sika AG
|
|
|
2,689,598
|
|
|
|
2.01
|
%
|
|
|
|
Manufactures construction materials, producing concrete and mixtures, mortar, sealants and adhesives, tooling resins, anti-static
industrial flooring, and acoustic materials. The company serves customers worldwide.
|
|
|
|
|
|
|
|
|
|
|
|
(Cost $1,482,802)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2,689,598
|
|
|
|
2.01
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
Chemicals — 1.64%
|
|
|
|
|
|
|
|
|
|
400
|
|
Givaudan SA
|
|
|
2,200,225
|
|
|
|
1.64
|
%
|
|
|
|
Manufactures and markets fragrances and flavors from natural and synthetic ingredients. The Company sells its products to manufactures
of perfumes, beverages, prepared foods, and consumer goods.
|
|
|
|
|
|
|
|
|
|
|
|
(Cost $1,207,567)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2,200,225
|
|
|
|
1.64
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
Computers — 0.80%
|
|
|
|
|
|
|
|
|
|
12,000
|
|
Logitech International SA
|
|
|
1,074,886
|
|
|
|
0.80
|
%
|
|
|
|
Engages in the development and marketing of hardware and software products that enable or enhance digital navigation, music and video
entertainment, gaming, social networking and audio and video communication.
|
|
|
|
|
|
|
|
|
|
|
|
(Cost $162,698)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,074,886
|
|
|
|
0.80
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
Diversified Financial Services — 3.23%
|
|
|
|
|
|
|
|
|
|
22,400
|
|
Julius Baer Group Ltd.
|
|
|
1,351,621
|
|
|
|
1.01
|
%
|
|
|
|
Provides private banking services. The company advises on wealth management, financial planning and investments; offers mortgage and
other lending, foreign exchange, securities trading, custody and execution services.
|
|
|
|
|
|
|
|
|
|
|
|
(Cost $1,027,660)
|
|
|
|
|
|
|
|
|
|
4,600
|
|
Swissquote Group Holding SA
|
|
|
1,659,937
|
|
|
|
1.24
|
%
|
|
|
|
Through its subsidiaries, offers online financial services. The company operates an online trading system which offers customers
real-time securities quotes on the Swiss Stock Exchange.
|
|
|
|
|
|
|
|
|
|
|
|
(Cost $444,009)
|
|
|
|
|
|
|
|
|
|
8,200
|
|
VZ Holding AG
|
|
|
1,316,200
|
|
|
|
0.98
|
%
|
|
|
|
Provides independent financial advice to private individuals and companies. The company consults on investment, tax and inheritance
planning and provides advice regarding insurance products and coverage.
|
|
|
|
|
|
|
|
|
|
|
|
(Cost $267,551)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4,327,758
|
|
|
|
3.23
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
Electric — 1.36%
|
|
|
|
|
|
|
|
|
|
10,000
|
|
BKW AG
|
|
|
1,818,505
|
|
|
|
1.36
|
%
|
|
|
|
Provides energy supply services. The company focuses on the production, transportation, trading and sale of energy. In addition to
energy supply, the company also develops, implements and operates energy solutions for its clients.
|
|
|
|
|
|
|
|
|
|
|
|
(Cost $623,498)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,818,505
|
|
|
|
1.36
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
Electronic Components & Equipment — 4.57%
|
|
|
|
|
|
|
|
|
|
58,300
|
|
ABB Ltd.
|
|
|
3,385,830
|
|
|
|
2.52
|
%
|
|
|
|
Provides power and automation technologies. The company operates under segments that include power products, power systems, automation
products, process automation, and robotics.
|
|
|
|
|
|
|
|
|
|
|
|
(Cost $1,894,633)
|
|
|
|
|
|
|
|
|
|
1,900
|
|
Comet Holding AG
|
|
|
751,171
|
|
|
|
0.56
|
%
|
|
|
|
Develops, produces, and distributes components and systems for x-ray tubes, vacuum condensers, and radio frequency, as well as other
medical products.
|
|
|
|
|
|
|
|
|
|
|
|
(Cost $381,063)
|
|
|
|
|
|
|
|
|
|
87,254
|
|
R&S Group Holding AG
|
|
|
1,996,328
|
|
|
|
1.49
|
%
|
|
|
|
Manufactures small and medium power and distribution transformers and other components in the utility, infrastructure, and industrial
sectors.
|
|
|
|
|
|
|
|
|
|
|
|
(Cost $992,256)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
6,133,329
|
|
|
|
4.57
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
Food — 15.11%
|
|
|
|
|
|
|
|
|
|
1,142,000
|
|
Aryzta AG 2
|
|
|
2,194,514
|
|
|
|
1.64
|
%
|
|
|
|
Produces and retails specialty bakery products. The Company produces French breads, pastries, continental breads, confections, artisan
breads, homestyle lunches, viennoiserie, patisserie, cookies, pizza, appetizers, and sweet baked goods.
|
|
|
|
|
|
|
|
|
|
|
|
(Cost $1,165,555)
|
|
|
|
|
|
|
|
|
|
840
|
|
Barry Callebaut AG
|
|
|
1,559,409
|
|
|
|
1.16
|
%
|
|
|
|
Manufactures cocoa and chocolate products. The Company markets to industrial food manufacturers, chocolatiers, pastry chefs, bakers,
and retailers globally.
|
|
|
|
|
|
|
|
|
|
|
|
(Cost $1,554,846)
|
|
|
|
|
|
|
|
|
|
164,000
|
|
Nestle SA
|
|
|
16,517,622
|
|
|
|
12.31
|
%
|
|
|
|
One of the world's largest food and beverage processing companies.
|
|
|
|
|
|
|
|
|
|
|
|
(Cost $9,388,046)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
20,271,545
|
|
|
|
15.11
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
Health Care — 2.59%
|
|
|
|
|
|
|
|
|
|
64,300
|
|
Sandoz Group AG
|
|
|
2,688,473
|
|
|
|
2.01
|
%
|
|
|
|
Manufactures and distributes generic and biosimilar medicines for the treatment of patients with diseases such as cancer, diabetes,
and arthritis.
|
|
|
|
|
|
|
|
|
|
|
|
(Cost $1,402,776)
|
|
|
|
|
|
|
|
|
|
1,600
|
|
Ypsomed Holding AG
|
|
|
781,459
|
|
|
|
0.58
|
%
|
|
|
|
Develops and manufactures custom-made injection systems for pharmaceutical and bio-technology companies.
|
|
|
|
|
|
|
|
|
|
|
|
(Cost $458,298)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3,469,932
|
|
|
|
2.59
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
Healthcare-Products — 6.97%
|
|
|
|
|
|
|
|
|
|
24,000
|
|
Alcon, Inc.
|
|
|
2,399,004
|
|
|
|
1.79
|
%
|
|
|
|
Manufactures eye care products. The company produces and markets vitreoretinal and cataract surgery, contact lenses, and refractive
technology products.
|
|
|
|
|
|
|
|
|
|
|
|
(Cost $1,541,567)
|
|
|
|
|
|
|
|
|
|
6,600
|
|
Medacta Group SA
|
|
|
978,010
|
|
|
|
0.73
|
%
|
|
|
|
Produces and distributes medical devices. The company develops, manufactures, and distributes orthopedic and neurosurgical medical
devices.
|
|
|
|
|
|
|
|
|
|
|
|
(Cost $720,575)
|
|
|
|
|
|
|
|
|
|
6,848
|
|
SKAN Group AG
|
|
|
647,010
|
|
|
|
0.48
|
%
|
|
|
|
Provides health care supplies. The Company offers isolators, cleanroom devices, and decontamination processes for the aseptic
production of the biopharmaceutical products.
|
|
|
|
|
|
|
|
|
|
|
|
(Cost $530,142)
|
|
|
|
|
|
|
|
|
|
1,900
|
|
Sonova Holding AG
|
|
|
684,275
|
|
|
|
0.51
|
%
|
|
|
|
Designs and produces wireless analog and digital in-the-ear and behind-the-ear hearing aids and miniaturized voice communications
systems.
|
|
|
|
|
|
|
|
|
|
|
|
(Cost $289,598)
|
|
|
|
|
|
|
|
|
|
221,085
|
|
Spineart SA 1,2
|
|
|
1,454,593
|
|
|
|
1.08
|
%
|
|
|
|
Designs and markets an innovative full range of spine products, including fusion and motion preservation devices, focusing on easy to
implant high-end products to simplify the surgical act.
|
|
|
|
|
|
|
|
|
|
|
|
(Cost $1,554,486)
|
|
|
|
|
|
|
|
|
|
8,000
|
|
Straumann Holding AG
|
|
|
1,311,126
|
|
|
|
0.98
|
%
|
|
|
|
Straumann Holding AG develops, produces and sells dental implants. The company manufactures metal devices implantable in the jaw, in
place of missing teeth, to which prostetic teeth are attached. Straumann has subsidiaries throughout Europe and North America. The Company sells its products worldwide.
|
|
|
|
|
|
|
|
|
|
|
|
(Cost $1,058,271)
|
|
|
|
|
|
|
|
|
|
5,700
|
|
Tecan Group AG
|
|
|
1,881,192
|
|
|
|
1.40
|
%
|
|
|
|
Manufactures and distributes laboratory automation components and systems. The products are mainly used by research and diagnostic
laboratories.
|
|
|
|
|
|
|
|
|
|
|
|
(Cost $785,966)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
9,355,210
|
|
|
|
6.97
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
Healthcare - Services — 0.74%
|
|
|
|
|
|
|
|
|
|
11,300
|
|
Galenica AG
|
|
|
997,315
|
|
|
|
0.74
|
%
|
|
|
|
Retails pharmaceutical products, and services customers in Switzerland. The Company offers health, beauty, and related products and
services.
|
|
|
|
|
|
|
|
|
|
|
|
(Cost $902,693)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
997,315
|
|
|
|
0.74
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
Industrials — 1.88%
|
|
|
|
|
|
|
|
|
|
1,252
|
|
Belimo Holding AG
|
|
|
895,717
|
|
|
|
0.67
|
%
|
|
|
|
Manufactures heating, ventilation and air conditioning equipment.
|
|
|
|
|
|
|
|
|
|
|
|
(Cost $144,479)
|
|
|
|
|
|
|
|
|
|
4,976
|
|
Georg Fischer AG
|
|
|
376,643
|
|
|
|
0.28
|
%
|
|
|
|
Greorg Fischer AG is a global supplier in the safe transportation of liquids and gases, in the production of lightweight casting
components and high-precision manufacturing technologies. Headquartered in Switzerland, it was founded in 1802. The company is located in over 30 countries. Georg fischer comprises of three divisions: GF Piping Systems, GF Casting Solutions,
and GF Machining.
|
|
|
|
|
|
|
|
|
|
|
|
(Cost $342,850)
|
|
|
|
|
|
|
|
|
|
230,000
|
|
OC Oerlikon Corp. AG
|
|
|
1,248,225
|
|
|
|
0.93
|
%
|
|
|
|
Manufactures industrial equipment. The Company produces protective coatings for precision tools and components, equipment for textile
production, and propulsion technology drive systems.
|
|
|
|
|
|
|
|
|
|
|
|
(Cost $2,526,045)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2,520,585
|
|
|
|
1.88
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
Information Technology — 0.43%
|
|
|
|
|
|
|
|
|
|
1,800
|
|
ALSO Holding AG
|
|
|
578,270
|
|
|
|
0.43
|
%
|
|
|
|
Wholesales information technology and consumer electonics products. The Company's products include computer hardware and software.
|
|
|
|
|
|
|
|
|
|
|
|
(Cost $512,678)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
578,270
|
|
|
|
0.43
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
Insurance — 7.18%
|
|
|
|
|
|
|
|
|
|
4,900
|
|
Baloise Holding AG
|
|
|
1,002,015
|
|
|
|
0.75
|
%
|
|
|
|
Offers group and individual life, health, accident, liability property, and transportation insurance to customers in Europe. The
Company also offers private banking and asset management services.
|
|
|
|
|
|
|
|
|
|
|
|
(Cost $720,253)
|
|
|
|
|
|
|
|
|
|
6,600
|
|
Helvetia Holding AG
|
|
|
1,142,315
|
|
|
|
0.85
|
%
|
|
|
|
Provides a broad range of life, casualty, liability, accident and transportation insurance in Switzerland and in other European
countries. The Company insures individuals, property such as vehicles and buildings, and consumer goods and personal belongings
|
|
|
|
|
|
|
|
|
|
|
|
(Cost $570,981)
|
|
|
|
|
|
|
|
|
|
2,450
|
|
Swiss Life Holding AG
|
|
|
2,050,501
|
|
|
|
1.53
|
%
|
|
|
|
Provides life insurance and institutional investment management.
|
|
|
|
|
|
|
|
|
|
|
|
(Cost $560,146)
|
|
|
|
|
|
|
|
|
|
9,000
|
|
Zurich Insurance Group AG
|
|
|
5,439,156
|
|
|
|
4.05
|
%
|
|
|
|
Provides insurance-based financial services. The company offers general and life insurance products and services for individuals,
small businesses, commercial enterprises, mid-sized and large corporations, and multinational companies.
|
|
|
|
|
|
|
|
|
|
|
|
(Cost $2,889,300)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
9,633,987
|
|
|
|
7.18
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
Machinery-Diversified — 0.85%
|
|
|
|
|
|
|
|
|
|
22,000
|
|
Accelleron Industries AG
|
|
|
1,143,358
|
|
|
|
0.85
|
%
|
|
|
|
Develops, produces, and services turbochargers and large turbocharging components. The Company offers turbocharging technologies and
optimization solutions for engines thereby reducing the environmental impact with less fuel emissions.
|
|
|
|
|
|
|
|
|
|
|
|
(Cost $386,769)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,143,358
|
|
|
|
0.85
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
Metal Fabricate/Hardware — 1.34%
|
|
|
|
|
|
|
|
|
|
11,500
|
|
SFS Group AG
|
|
|
1,799,538
|
|
|
|
1.34
|
%
|
|
|
|
Provides automotive products, building and electronic components, flat roofing and solar fastening systems. The company operates
production facilities in Asia, Europe and North America.
|
|
|
|
|
|
|
|
|
|
|
|
(Cost $778,227)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,799,538
|
|
|
|
1.34
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
Packaging & Containers — 1.62%
|
|
|
|
|
|
|
|
|
|
97,000
|
|
SIG Combibloc Group AG
|
|
|
2,168,716
|
|
|
|
1.62
|
%
|
|
|
|
The company, through its subsidiaries, manufactures and produces bottling machines and systems for the food and beverage industries.
The company serves customers worldwide.
|
|
|
|
|
|
|
|
|
|
|
|
(Cost $1,384,254)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2,168,716
|
|
|
|
1.62
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
Pharmaceuticals — 23.65%
|
|
|
|
|
|
|
|
|
|
23,200
|
|
Galderma Group AG 2
|
|
|
2,161,721
|
|
|
|
1.61
|
%
|
|
|
|
Delivers scirnce-based portfolio of brands and services that span the full spectrum of self-care dermatology market through injectable
aesteticss, dermatological skincare, and therapeutic dermatology. The company serves customerss worldwide..
|
|
|
|
|
|
|
|
|
|
|
|
(Cost $1,367,362)
|
|
|
|
|
|
|
|
|
|
140,000
|
|
Novartis AG
|
|
|
16,123,525
|
|
|
|
12.02
|
%
|
|
|
|
One of the leading manufacturers of branded and generic pharmaceutical products.
|
|
|
|
|
|
|
|
|
|
|
|
(Cost $6,851,499)
|
|
|
|
|
|
|
|
|
|
41,880
|
|
Roche Holding AG
|
|
|
13,434,566
|
|
|
|
10.02
|
%
|
|
|
|
Develops and manufactures pharmaceutical and diagnostic products. Produces prescription drugs to treat cardiovascular, infectious and
autoimmune diseases and for other areas including dermatology and oncology.
|
|
|
|
|
|
|
|
|
|
|
|
(Cost $7,268,153)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
31,719,812
|
|
|
|
23.65
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
Private Equity — 2.64%
|
|
|
|
|
|
|
|
|
|
2,350
|
|
Partners Group Holding AG
|
|
|
3,538,024
|
|
|
|
2.64
|
%
|
|
|
|
A global private markets investment management firm with investment programs under management in private equity, private real estate,
private infrastructure and private debt. The firm manages a broad range of customized portfolios for an international clientele of institutional investors. Partners Group is headquartered in Zug, Switzerland.
|
|
|
|
|
|
|
|
|
|
|
|
(Cost $1,796,137)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3,538,024
|
|
|
|
2.64
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
Retail — 6.41%
|
|
|
|
|
|
|
|
|
|
43,400
|
|
Cie Financiere Richemont SA
|
|
|
6,883,907
|
|
|
|
5.13
|
%
|
|
|
|
Manufactures and retails luxury goods. Produces jewelry, watches, leather goods, writing instruments and men’s and women’s wear.
|
|
|
|
|
|
|
|
|
|
|
|
(Cost $3,343,993)
|
|
|
|
|
|
|
|
|
|
40,000
|
|
Swatch Group AG - Registered Shares
|
|
|
1,718,926
|
|
|
|
1.28
|
%
|
|
|
|
Manufactures finished watches, movements and components. Produces components necessary to its various watch brand companies. The
company also operates retail boutiques.
|
|
|
|
|
|
|
|
|
|
|
|
(Cost $2,466,618)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
8,602,833
|
|
|
|
6.41
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
Semiconductors — 0.82%
|
|
|
|
|
|
|
|
|
|
78,605
|
|
ams-OSRAM AG 2
|
|
|
1,100,501
|
|
|
|
0.82
|
%
|
|
|
|
Designs and manufactures advanced sensor solutions. The company also delivers a broad range of technology solutions for consumer
electronics and communication device manufactures.
|
|
|
|
|
|
|
|
|
|
|
|
(Cost $2,267,258)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,100,501
|
|
|
|
0.82
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
Transportation — 1.51%
|
|
|
|
|
|
|
|
|
|
7,400
|
|
Kuehne + Nagel International AG
|
|
|
2,024,681
|
|
|
|
1.51
|
%
|
|
|
|
Transports freight worldwide. The company operates sea, land, and rail freight transportation businesses and warehousing and
distribution facilities.
|
|
|
|
|
|
|
|
|
|
|
|
(Cost $2,030,349)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2,024,681
|
|
|
|
1.51
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Common Stock
|
|
|
|
|
|
|
|
|
|
|
|
(Cost $73,594,213)
|
|
|
125,256,382
|
|
|
|
93.38
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Limited Partnership — 0.42%
|
|
|
|
|
|
|
|
|
Biotechnology — 0.42%
|
|
|
|
|
|
|
|
|
|
3,294,705
|
|
Aravis Biotech II, Limited Partnership 1,2
|
|
|
566,218
|
|
|
|
0.42
|
%
|
|
|
|
Makes early stage venture investments in the biotechnology & pharmaceuticals industry.
|
|
|
|
|
|
|
|
|
|
|
|
(Cost $213,885)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
566,218
|
|
|
|
0.42
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Limited Partnership
|
|
|
|
|
|
|
|
|
|
|
|
(Cost $213,885)
|
|
|
566,218
|
|
|
|
0.42
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
Short-Term Investment — 0.27%
|
|
|
|
|
|
|
|
|
|
364,226
|
|
U.S. Bank Money Market Deposit Account, 1.55%
|
|
|
364,226
|
|
|
|
0.27
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(Cost $364,226)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
364,226
|
|
|
|
0.27
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Short-Term Investment
|
|
|
|
|
|
|
|
|
|
|
|
(Cost $364,226)
|
|
|
364,226
|
|
|
|
0.27
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Investments 5
|
|
|
|
|
|
|
|
|
|
|
|
(Cost $74,172,324)
|
|
|
126,186,826
|
|
|
|
94.07
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other Assets Less Liabilities 5
|
|
|
7,950,855
|
|
|
|
5.93
|
%
|
|
|
|
Net Assets
|
|
$
|
134,137,681
|
|
|
|
100.00
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Asset Value Per Share:
|
|
|
|
|
|
|
|
|
|
|
|
($134,137,681 ÷ 12,990,705
shares outstanding,
$0.001 par value: 50 million
shares authorized)
|
|
|
|
|
|
$
|
10.33
|
|
|
|
|
|
|
|
|
|
|
|
|
|
See Notes to Schedule of Investments
|
|
THE SWISS HELVETIA FUND, INC.
Notes to Schedule of Investments (Unaudited)
Various inputs are used to determine the value of the Fund’s investments. These inputs are summarized in the three broad levels listed below:
Level 1—unadjusted quoted prices in active markets for identical assets and liabilities
Level 2—other significant observable inputs (including quoted prices of similar securities, interest rates, prepayment speeds, credit risk, etc.)
Level 3—significant unobservable inputs (including the Fund’s own assumptions in determining the fair value of investments)
The inputs or methodology used for valuing securities are not an indication of the risk associated with investing in those securities.
The following is a summary of the inputs used to value the Fund’s investments as of September 30, 2024:
TOPIC 820 TABLE
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Investments in Securities*
|
|
Level 1
Quoted Prices
|
|
|
Level 2
Other Significant
Observable Inputs
|
|
|
Level 3
Significant
Unobservable Inputs
|
|
|
Investments Valued at NAV**
|
|
|
Total
|
|
Common Stock
|
|
$
|
123,801,789
|
|
|
$
|
-
|
|
|
$
|
1,454,593
|
|
|
$
|
-
|
|
|
$
|
125,256,382
|
|
Preferred Stock
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
Limited Partnership
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
566,218
|
|
|
|
566,218
|
|
Short Term Investment
|
|
|
364,226
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
364,226
|
|
Total Investments in Securities
|
|
$
|
124,166,015
|
|
|
$
|
-
|
|
|
$
|
1,454,593
|
|
|
$
|
566,218
|
|
|
$
|
126,186,826
|
|
* Please see the Schedule of Investments for industry classifications.
** As of September 30, 2024, certain of the Fund’s investments were valued using net asset value (“NAV”) per share (or its
equivalent) as a practical expedient for fair value and have been excluded from the fair value hierarchy in accordance with ASU 2015-07. The fair value amount presented in this table is intended to permit reconciliation of the amounts presented in
the fair value hierarchy to the amounts presented in the schedule of investments.
The Fund values its investment in a private equity limited partnership in accordance with Accounting Standards Codification 820-10-35,
“Investments in Certain Entities that Calculate Net Asset Value Per Share (Or its Equivalent)” (“ASC 820-10-35”). ASC 820-10-35 permits a reporting entity to measure the fair value of an investment that does not have a readily determinable fair
value, based on the NAV of the investment as a practical expedient, without further adjustment, unless it is probable that the investment will be sold at a value significantly different than the NAV. If the NAV of the investment is not as of the
Fund’s measurement date, then the NAV should be adjusted to reflect any significant events that may change the valuation. Inputs and valuation techniques for these adjustments may include fair valuations of the partnership and its portfolio
holdings provided by the partnership’s general partner or manager, other available information about the partnership’s portfolio holdings, values obtained on redemption from other limited partners, discussions with the partnership’s general partner
or manager and/or other limited partners and comparisons of previously-obtained estimates to the partnership’s audited financial statements. In using the unadjusted NAV as a practical expedient, certain attributes of the investment that may impact
its fair value are not considered. Attributes of those investments include the investment strategies of the privately held companies and may also include, but are not limited to, restrictions on the investor’s ability to redeem its investments at
the measurement date and any unfunded commitments.
Level 3 securities, which are listed in Note 3 to the Schedule of Investments, consist of the Fund’s investments in privately-held companies.
Inputs and valuation techniques used by the Fund to value its Level 3 investments in privately-held companies may include the following:
acquisition cost; fundamental analytical data; discounted cash flow analysis; nature and duration of restrictions on disposition of the investment; public trading of similar securities of similar issuers; economic outlook and condition of the
industry in which the issuer participates; financial condition of the issuer; and the issuer’s prospects, including any recent or potential management or capital structure changes. Although these valuation inputs may be observable in the
marketplace as is characteristic of Level 2 investments, the privately-held companies, categorized as Level 3 investments, generally are highly illiquid in terms of resale.
When valuing Level 3 investments, management also may consider potential events that could have a material impact on the operations of a
privately-held company. Not all of these factors may be considered or available, and other relevant factors may be considered on an investment-by-investment basis.
The following is a reconciliation of Level 3 assets for which significant unobservable inputs were used to determine fair value.
LEVEL 3 ROLLFORWARD TABLE
|
|
|
Common Stock
|
|
|
Preferred Stock
|
|
|
Total
|
|
Balance as of December 31, 2023
|
|
$
|
1,341,160
|
|
|
$
|
5,177
|
|
|
$
|
1,346,338
|
|
Change in Unrealized Appreciation/Depreciation
|
|
|
3,120,481
|
|
|
|
1,927,021
|
|
|
|
5,047,501
|
|
Net Realized Gain (Loss)
|
|
|
(3,005,586
|
)
|
|
|
(1,932,198
|
)
|
|
|
(4,937,784
|
)
|
Gross Purchases
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
Gross Sales
|
|
|
(1,462
|
)
|
|
|
-
|
|
|
|
(1,462
|
)
|
Transfer out of Level 3
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
Balance as of September 30, 2024
|
|
$
|
1,454,593
|
|
|
$
|
-
|
|
|
$
|
1,454,593
|
|
Change in unrealized appreciation (depreciation) during the period for Level 3 investments held at September 30, 2024
|
|
|
114,923
|
|
|
|
-
|
|
|
|
114,923
|
|
(a)
|
The noted amounts of change in unrealized appreciation/depreciation relate to the fair value of Level 3 assets held on
September 30, 2024.
|